As shown in Supplementary data online, Table S3, the finding that TRL/remnant-C remained a significant predictor of CHD risk in a model adjusted for apoB, or in a model that included LDL-C, was validated in this cohort. The gene discussed is APOB; the disease is coronary artery disorder.